Treatment of Chronic Angle-Closure Glaucoma with ≥180° Iridotrabecular Contact

Clinical Scenario

This protocol addresses patients classified as primary angle-closure suspect (PACS): ≥180 degrees of iridotrabecular contact of the anterior chamber angle, with no intraocular pressure elevation, no peripheral anterior synechiae, and no glaucomatous optic neuropathy.

Treatment Approach

Management in this setting involves topical ocular hypotensive agents directed at lowering intraocular pressure. The complete selection criteria, agent sequencing, and monitoring framework are detailed in the full protocol.

Specific agents, dosing guidance, and follow-up intervals are not shown here — access the full structured regimen below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.ophtha.2025.12.030
Primary angle-closure suspect (PACS): ≥180 degrees iridotrabecular contact (ITC) without intraocular pressure (IOP) elevation, peripheral anterior synechiae (PAS), or glaucomatous optic neuropathy
Some PACS patients develop increased IOP despite LPI and eventually require topical ocular hypotensive agents.

View source ↗